BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17963033)

  • 1. Abstracts of the 13th International Congress on Cardiovascular Pharmacotherapy. November 29-December 2, 2007. Antalya, Turkey.
    Remme WJ
    Cardiovasc Drugs Ther; 2007 Nov; 21 Suppl 1(1):S6-43. PubMed ID: 17963033
    [No Abstract]   [Full Text] [Related]  

  • 2. Abstracts of the 11th International Congress on Cardiovascular Pharmacotherapy. Montreal, Canada, 18-21 May 2002.
    Cardiovasc Drugs Ther; 2002; 16 Suppl 1():5-116. PubMed ID: 12108434
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts of the 10th International Congress on Cardiovascular Pharmacotherapy. Kyoto, Japan, 27-31 March 2001.
    Cardiovasc Drugs Ther; 2001 Mar; 15 Suppl 1():1-166. PubMed ID: 11501560
    [No Abstract]   [Full Text] [Related]  

  • 4. 7th International Symposium on Cardiovascular Pharmacotherapy. Jerusalem, Israel, June 1-5, 1997. Abstracts.
    Cardiovasc Drugs Ther; 1997 Jun; 11 Suppl 2():315-421. PubMed ID: 9255319
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of drug discovery for treatment of cardiovascular diseases.
    Kennedy C
    Future Med Chem; 2013 Mar; 5(4):355-7. PubMed ID: 23495678
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation of vascular mechanisms: bridging the gap between basic research and clinical trials.
    Collier J; Vallance P
    Trends Pharmacol Sci; 1993 Jul; 14(7):257-8. PubMed ID: 8212320
    [No Abstract]   [Full Text] [Related]  

  • 7. Abstracts of the 12th International Congress on Cardiovascular Pharmacotherapy. May 7-10, 2003. Barcelona, Spain.
    Cardiovasc Drugs Ther; 2003; 17(5-6):481-504. PubMed ID: 15318397
    [No Abstract]   [Full Text] [Related]  

  • 8. 8th International Symposium on Cardiovascular Pharmacotherapy. Amsterdam, The Netherlands. March 28 April 1, 1999. Abstracts.
    Cardiovasc Drugs Ther; 1999 Mar; 13(1):1-86. PubMed ID: 10405623
    [No Abstract]   [Full Text] [Related]  

  • 9. Epicardial fat: a new cardiovascular therapeutic target.
    Iacobellis G
    Curr Opin Pharmacol; 2016 Apr; 27():13-8. PubMed ID: 26848943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular receptors as drug targets. Eur omega Conferences' Cardiovascular receptors as drug targets. Institut Pasteur, Paris, France, 3-4 October 1996.
    Maack T
    Mol Med Today; 1997 Mar; 3(3):101-2. PubMed ID: 9095483
    [No Abstract]   [Full Text] [Related]  

  • 11. 5th International Symposium on Cardiovascular Pharmacotherapy. August 16-20, 1993. Abstracts.
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 2():397-478. PubMed ID: 8105879
    [No Abstract]   [Full Text] [Related]  

  • 12. The Future of Cardiovascular Therapeutics.
    MacRae CA; Roden DM; Loscalzo J
    Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of sex on cardiovascular drug responses: role of estrogen.
    Abdel-Rahman AA
    Curr Opin Pharmacol; 2017 Apr; 33():1-5. PubMed ID: 28340373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9th International Congress on Cardiovascular Pharmacotherapy. Salvador, Bahia, Brazil, March 26-30, 2000. Abstracts.
    Cardiovasc Drugs Ther; 2000 Mar; 14(2):117-234. PubMed ID: 10907050
    [No Abstract]   [Full Text] [Related]  

  • 15. The application of phenotypic high-throughput screening techniques to cardiovascular research.
    Etzion Y; Muslin AJ
    Trends Cardiovasc Med; 2009 Aug; 19(6):207-12. PubMed ID: 20211437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abstracts of the Fourth Annual Congress of Update in Cardiology and Cardiovascular Surgery. November 28-December 2, 2008. Antalya, Turkey.
    Heart Surg Forum; 2008 Dec; 11 Suppl 2():S5-165. PubMed ID: 19767275
    [No Abstract]   [Full Text] [Related]  

  • 17. Abstracts of the 3rd Annual Congress of Update in Cardiology and Cardiovascular Surgery. November 28 - December 02, 2007. Antalya, Turkey.
    Cardiovasc Drugs Ther; 2007 Nov; 21 Suppl 1():S44-94. PubMed ID: 17963034
    [No Abstract]   [Full Text] [Related]  

  • 18. Organs-on-chip models for cardiovascular drug development.
    Zimmermann WH
    Cardiovasc Res; 2021 Nov; 117(12):e164-e165. PubMed ID: 34347045
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular-Active Venom Toxins: An Overview.
    Rebello Horta CC; Chatzaki M; Rezende BA; Magalhães Bde F; Duarte CG; Felicori LF; Ribeiro Oliveira-Mendes BB; do Carmo AO; Chávez-Olórtegui C; Kalapothakis E
    Curr Med Chem; 2016; 23(6):603-22. PubMed ID: 26812904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics?
    Roden DM
    Can J Cardiol; 2013 Jan; 29(1):58-66. PubMed ID: 23200096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.